InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by MYERS ROBERT L. Officer active across 2 companies, notably Predictive Oncology Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €9k. History available since 23 September 2021. The latest transaction was disclosed on 2 December 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
1,667 sharesCommon StockSEC:0001171843-23-005892:0
8,795 shares@ US$0.56866.5% of flowCommon StockSEC:0001415889-22-011944:0
Ideal exit: 29 Aug 2023 (T+270)
33,333 sharesCommon StockSEC:0001415889-22-009970:0
16,125 shares@ US$0.30326.7% of flowCommon StockSEC:0001415889-22-005364:0
Ideal exit: 14 Feb 2023 (T+270)
33,334 shares@ US$1.1343.6% of flowCommon Stock, $.01 par valueSEC:0001179110-21-008909
33,334 shares@ US$1.1346.6% of flowCommon Stock, $.01 par valueSEC:0001179110-21-008909:0
15,685 sharesCommon StockSEC:0001179110-16-017475:0
7 of 7 declarations
About MYERS ROBERT L
MYERS ROBERT L is a chief financial officer at Predictive Oncology Inc. and Skyline Medical Inc. The 7 filings recorded, all within the full sample held, cover the period from 2016-01-07 to 2023-09-27 and show EUR 9371 of purchases and EUR 0 of sales, with option exercise as the most common transaction nature.
